FGF6 and Insulin resistance: Off-target effects of AAV9 were ruled out by detecting the expression of GFP, and the amelioration of insulin resistance in HFD-fed mice was only observed in the skeletal muscle of mice treated with AAV9-FGF6, but not in iWAT, eWAT, or liver.